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Objective: Cognitive Behavioral Therapy (CBT) is an effective intervention for patients
with panic disorder (PD). From a theoretical perspective, Eye Movement Desensitization
and Reprocessing (EMDR) therapy could also be useful in the treatment of PD because:
(1) panic attacks can be experienced as life threatening; (2) panic memories specific
to PD resemble traumatic memories as seen in posttraumatic stress disorder (PTSD);
and (3) PD often develops following a distressing life event. The primary objective of this
Randomized Controlled Trial (RCT), was to compare EMDR therapy with CBT for PD
and determine whether EMDR is not worse than CBT in reducing panic symptoms and
improving Quality Of Life (QOL).
Methods: Two-arm (CBT and EMDR) parallel RCT in patients with PD (N = 84). Patients
were measured at baseline (T1), directly after the last therapy session (T2), and 3 months
after ending therapy (T3). Non-inferiority testing (linear mixedmodel with intention-to-treat
analysis) was applied. Patients were randomly assigned to 13 weekly 60-min sessions
of CBT (N = 42) or EMDR therapy (N = 42). Standard protocols were used. The
primary outcome measure was severity of PD at T3, as measured with the Agoraphobic
Cognitions Questionnaire (ACQ), the Body Sensations Questionnaire (BSQ), and the
Mobility Inventory (MI). The secondary outcome measure was QOL, as measured with
the World Health Organization Quality of Life short version (WHOQOL-Bref), at T3.
Results: The severity of PD variables ACQ and BSQ showed non-inferiority
of EMDR to CBT, while MI was inconclusive (adjusted analyses). Overall QOL
and general health, Psychological health, Social relationships, and Environment
showed non-inferiority of EMDR to CBT, while Physical health was inconclusive.
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Conclusion: EMDR therapy proved to be as effective as CBT for treating PD patients.
Trial Registration: Dutch Trial Register, Nr. 3134 http://www.trialregister.nl/trialreg/
admin/rctview.asp?TC=3134
Keywords: EMDR, CBT, Panic disorder, psychotherapy, RCT
INTRODUCTION
Panic disorder (PD) is characterized by recurrent, unexpected
panic attacks and hyperarousal symptoms such as palpitations,
pounding heart, chest pain, sweating, trembling, or shaking
(Frances, 2004). These symptoms are often experienced as
catastrophic and can have a great impact on daily life (Frances,
2004). Prevalence rates of PD are around 2.1% (Batelaan et al.,
2006). Women are twice as likely to develop PD compared to
men. Up to 50% of patients meet the criteria of agoraphobia
(Weissman et al., 1997). In addition, widowed, lower educated,
and divorced persons are more likely to experience panic attacks
(Batelaan et al., 2006).
Several controlled treatment effect studies have shown that
cognitive behavioral therapy (CBT), particularly interoceptive
exposure, is the most effective intervention for PD (Barlow et al.,
1989, 2000; Öst et al., 2004; Furukawa et al., 2007). Typical
for this approach is that patients are exposed to exercises that
evoke the physical sensations associated with a panic attack,
such as hyperventilation, in order to experience that the worst
expected outcome (e.g., dying) does not occur ( i.e., “expectancy
violation”). Approximately 40-90% of patients treated with CBT
are panic free directly after treatment (Bakker et al., 1999).
Variations in treatment effects are strongly determined by the
selected study population (e.g., with/without comorbidity) and
the content of CBT (e.g., whether in vivo exposure is offered)
(Bakker et al., 1999; Rief et al., 2000). Furthermore, several
studies have shown that the quality of life (QOL) for patients
with PD improves after CBT (Telch et al., 1995; Davidoff et al.,
2012). Nevertheless, a group of patients still needs additional
treatment after CBT because some patients do not benefit,
while others do not make a full recovery or develop other
affective disorders (Van Balkom et al., 1996; Bakker et al.,
1999). EyeMovement Desensitization and Reprocessing (EMDR)
therapy is a treatment procedure for patients who suffer from
past traumatic experiences in the present (Shapiro, 2002). In
EMDR therapy the focus is on resolving disturbing memories
of distressing or traumatic events by focusing on the memory
while making eye movements at the same time. Besides CBT,
EMDR is recommended as a first-line treatment for psychological
trauma (Bisson et al., 2007). Despite the well-examined efficacy
of EMDR for Post-Traumatic Stress Disorder (PTSD), the
applicability of EMDR for other anxiety disorders, like PD,
has hardly been examined (De Jongh and ten Broeke, 2009).
There are several reasons why EMDR could be useful in the
treatment of PD. Firstly, panic attacks likely occur unexpectedly,
are experienced as distressing, cause a subjective response of
fear or helplessness, and can be considered life threatening
(McNally and Lukach, 1992; Hagenaars et al., 2009). Secondly,
there are indications that panic memories in PD resemble
traumatic memories as seen in PTSD (Hagenaars et al., 2009).
Thirdly, there are indications that PD often develops after one
or more distressing life events (Faravelli and Pallanti, 1989;
Horesh et al., 1997). The few available studies on EMDR as
PD treatment (Goldstein and Feske, 1994; Feske and Goldstein,
1997; Goldstein et al., 2000), all performed by the same research
group, found a decrease in panic complaints and anticipatory
anxiety in most EMDR-treated patients (Goldstein and Feske,
1994). Goldstein et al. (2000) showed that EMDR was superior to
the waitlist condition on panic and agoraphobia severity, albeit
no significant change was apparent on cognitive measures or on
panic attack frequency. Importantly, these studies only included
a short EMDR procedure and some essential parts of the current
EMDR protocol (e.g., the installation of a “future template”)
were lacking (De Jongh and ten Broeke, 2009). More recently,
a pilot study comparing 12 sessions of EMDR to CBT for PD,
found no differences between both treatments, except that EMDR
resulted in significantly less frequent panic attacks (Faretta,
2013). Although the effect of EMDR on QOL in PD patients was
not examined, QOL seems to be an important outcome measure
as PD is a very stressful condition (Trompenaars et al., 2005).
In conclusion, CBT has been found to be effective for
a considerable number of patients suffering from PD. The
treatment of PD with EMDR seems plausible, but previous
studies are limited and replications are needed. This is the first
randomized controlled trial (RCT) that directly compares CBT
and EMDR therapy in PD patients regarding PD severity and
QOL.
The primary aim of this RCTwas to examine if EMDR therapy
is not worse than CBT among patients with PD on symptom
severity and QOL 3 months post-treatment. It is hypothesized
that EMDR is not worse than CBT.
MATERIALS AND METHODS
Design
The study was approved by the Medical Ethical Board of the St.
Elisabeth hospital in Tilburg, the Netherlands and was registered
in the Dutch Trial Register (www.trialregister.nl, NTR 3134). All
included patients gave their written consent before enrollment.
This study is a two-arm parallel RCT, including CBT and EMDR
therapy.
Participants
Patients were recruited, assessed, and treated at the department
of psychiatry, St. Elisabeth hospital, Tilburg, the Netherlands
between February 2010 and December 2013. Advertisements
were placed in a local newspaper to inform people about
the existence of our study. When someone wanted to
participate he or she had to visit his or her general
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practitioner. Patients were referred to the hospital by general
practitioners.
Inclusion criteria were: (1) age between 18 and 65 years old;
(2) the presence of a SCID-I primary diagnosis of PD (First et al.,
1997); and (3) sufficient knowledge of the Dutch language.
Exclusion criteria were: (1) comorbid diagnosis of dementia,
psychosis, severe depression, bipolar disorder, and/or another
psychiatric disorder that was more prominent than the PD;
(2) use of more than 20 standard units of alcohol a week;
and (3) use of benzodiazepines and/or other sedative agents
(De Jongh and ten Broeke, 2006). This last criterion was
added because benzodiazepines or other sedative agents are
likely to interfere with the level of arousal that is needed for
EMDR therapy to be effective (Little et al., 2017). Patients
who use modern antidepressants (e.g., Selective Serotonin
Reuptake Inhibitors (SSRIs) or Serotonin and Norepinephrine
Reuptake Inhibitors (SNRIs) and/or classic antidepressants (e.g.,
Tricyclic Antidepressants (TCA) were required to be on a
stable medication dose (i.e., unchanged dosage of medication),
6 weeks prior to trial until the end. Patients were not
allowed to attend any form of therapy during the whole trial.
Patients not eligible for participation were offered treatment as
usual.
Measures
The primary outcome measure was the severity of the PD,
assessed with the Agoraphobic Cognitions Questionnaire (ACQ),
which measures the degree of catastrophic cognitions when
feeling anxious or tense (Chambless et al., 1984). The two
subscales have a good internal consistency. The discriminant
validity and construct validity are also good (Chambless et al.,
1985).
The Body Sensations Questionnaire (BSQ) measures anxiety
about bodily sensations and consists of two questionnaires;
while the BSQ1 assesses the amount of fear, the BSQ2 measures
how often the sensations are experienced when the patient
feels anxious or tense (Chambless et al., 1984). The internal
consistency and the test-retest reliability of the BSQ are good.
Furthermore, the BSQ has good discriminant- and construct
validity (Chambless et al., 1985).
The Mobility Inventory (MI) measures the degree to which
places or situations are avoided with a trusted companion (MI-
ac) and when the patient is alone (MI-al) (Chambless et al., 1985).
Both subscales have a good internal consistency, discriminant
validity and construct validity (Chambless et al., 1985). For ACQ,
BCQ, and MI, lower scores indicate better outcomes.
The secondary outcome measure, QOL, was assessed with
the World Health Organization Quality of Life short version
(WHOQOL-Bref) (De Vries and van Heck, 1995). This measure
consists of one generic facet (Overall quality of life and general
health) and four domains (i.e., “Physical health,” “Psychological
health,” “Social relationships,” and “Environment”) (De Vries
and van Heck, 1995). Higher scores indicate better QOL.
The WHOQOL-Bref is sensitive for changes over time and
for treatment influences. The psychometric properties of
the WHOQOL-Bref are also good (Trompenaars et al.,
2005).
Procedure
All patients were first screened by a psychiatrist who conducted
a regular psychiatric interview, including the registration of the
participants’ medical status and medication use. Participation
was voluntary and patients could withdraw from the study
at any time without specifying a reason. After referral by a
psychiatrist and before randomization, patients were screened
with the Structured Clinical Interview for DSM-IV Axis I
disorders (SCID-I) (First et al., 1997). The SCID-I was conducted
by independent clinicians who were trained intensively during a
2-day workshop.
Patients eligible for participation were randomized to one of
two treatment groups. Randomization was carried out by an
independent secretary, who had 84 sealed envelopes, of which 42
contained a note with “EMDR” written on it, and 42 included a
note with “CBT” on it. In both groups, a standardized treatment
protocol was used. For each eligible patient, random assignment
of sealed envelopes was performed. Before randomization,
patients signed an informed consent. Patients were measured at
baseline (T1), post-treatment (T2), and 3 months follow-up (T3),
and received no financial compensation for participation.
Treatment
In total, six licensed clinical psychologists (three men, three
women) performed the EMDR and CBT treatments. In both
groups, standardized treatment protocols were used. Therapists
who performed EMDR therapy (one man, one woman) were
both accredited practitioners by the European association.
Therapists performing CBT treatment (three men, two women)
were accredited CBT therapists by the Dutch National CBT
Association.
The CBT protocol is the Dutch version of Craske and Barlow’s
(2008) and consists of 13 weekly sessions lasting about 60 min
each (Craske and Barlow, 2008). During the first part (psycho-
education), the patient is informed about panic attacks and PD.
The second part consists of teaching and applying relaxation
exercises which help the patient to reduce general anxiety. The
third part consists of interoceptive exposure exercises in order
to become accustomed to, and to cope with, the fear of bodily
sensations. The fourth part is cognitive therapy in which the
patients learn to recognize their automatic, anxious thoughts and
formulate alternative, more adaptive thoughts. Finally, in vivo
exposure consisted of learning patients to cope with the anxiety
experienced during situations or activities that are feared and
avoided by using an anxiety hierarchy (Kampman et al., 2004).
The EMDR treatment protocol is the Dutch version (De Jongh
and ten Broeke, 2006) of Shapiro’s EMDR protocol (Shapiro,
2001) and consists of 13 weekly sessions lasting about 60 min
each. In this protocol, a patient is first informed about EMDR
therapy, traumatic memories are identified, and the course of
current symptoms is evaluated. In the present study the case
conceptualization was conducted according to the “first method”
of the “Two Method Approach” that deals with symptoms
whereby memories of the etiological and/or aggravating events
were meaningfully specified on a time line. To this end, the
memories of the distressing events that were assumed to play a
key role in the acquisition and maintenance of the condition and
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36 Excluded
2 No full diagnosis of PD 
2 Did not master Dutch language 
2 Age over 65 
11 Interfering comorbid psychiatric
and/or somatic disorder
19 Refused to participate
120 Assessed for eligibility
84 Randomized
38 Included in intention-to-treat analysis
25 Completed all time points
3 Completed T1 and T2 and not T3
10 Completed T1 and not T2 and not T3
39 Included in intention-to-treat analysis
29 Completed all time points
5 Completed T1 and T2 and not T3
5 Completed T1 and not T2 and not T3
42 Allocated to CBT 42 Allocated to EMDR therapy
4 Did not participate
1 Due to pregnancy
3 Refused to participate
3 Did not participate
1 Acute somatic disorder
2 Refused to participate
FIGURE 1 | Flow of participants through the trial.
evoked distress, were determined. Subsequently, the memories
that evoked the most disturbance, e.g., the first or worst panic
attack, were reprocessed first using working memory taxation
by listening to alternating audio tones. Subsequently, other
memories that were considered to contribute to a patient’s
current symptoms were targeted in the same way (De Jongh et al.,
2010). During EMDR therapy, patients are asked to report what
associations come to mind and the patient is guided to refocus
on that association. This is continued until the patient no longer
reports any distress related to the target image. Afterwards, the
patient is asked to formulate a positive belief regarding the target
image.
Supervision and Treatment Integrity
To each treatment group, 20 h of group supervision by
an independent qualified EMDR or CBT supervisor were
given. Additional supervision by telephone or e-mail was
provided on request. All patients were asked permission to
make video recordings of the treatment sessions, to ensure
that therapists adhered to the treatment protocol. During
the study, therapists had supervision sessions in which
adherence to the therapist protocol was evaluated and discussed
to maintain quality and homogeneity of the intervention
protocol.
Statistical Analysis
According to the method of Faul et al. (2009), a sample size
calculation was performed using G-Power 3.1.7 which showed
that in total, 102 patients would be needed (non-inferiority test,
effect size Cohen’s d = 0.5, one-sided alpha = 0.05, power =
0.80). Anticipating 20% drop out, 128 patients were needed.
For each outcome variable, linear mixed models (with ML
estimation) were specified including main effects of group, time
(categorical), and interaction effect group∗time. The dependence
of the repeated measures was taken into account by using the
unstructured error covariance pattern model. Covariates (i.e.,
age, gender, education, marital status, duration of complaints,
number of axis I diagnoses, received previous treatment, and
antidepressant treatment) were added to obtain adjusted results
under the missing at random assumption.
Non-inferiority testing was used to determine whether EMDR
is not worse than CBT (Piaggio et al., 2006, 2012). For ACQ,
BCQ, and MI, the null hypothesis is (EMDR - CBT) > δ, and
the alternative hypothesis is (EMDR - CBT) ≤ δ, where δ is the
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margin that is set at minimal clinical relevance. If the upper
bound of confidence interval of 90% is below δ, it is concluded
that EMDR is non-inferior to CBT. For ACQ and BCQ, the
margin was δ = 5, and for MI, the margin was δ = 8. The
margins of these questionnaires were determined by clinical
experts. For WHOQOL-BREF, the non-inferiority was reversed
and the margin was δ=−1 (Den Oudsten et al., 2013).
Group differences were analyzed at T3. Intention-to-treat
approach was used on the patients that started treatment, while
per-protocol approach was used as a sensitivity analysis on
patients that completed all treatments (Piaggio et al., 2006,
2012). For effect size measure, Cohen’s d was computed as
mean difference divided by baseline pooled standard deviation.
Statistical analyses were performed in SPSS version 19.0.
RESULTS
Figure 1 shows the patient flow through the trial. Despite an
extended inclusion period, in total, 120 patients could be assessed
for eligibility, from which 36 were excluded. Accordingly, were
randomized to both treatment groups: 42 patients to CBT and
42 to EMDR therapy. Table 1 displays the baseline and clinical
characteristics of both groups. No significant differences in age,
gender, education, marital status, and number of axis I diagnoses
at baseline were found. However, patients in the CBT group had
experienced significantly shorter duration of PD and received
significantly less previous treatment than those in the EMDR
group. Significantly more patients in the EMDR group received
antidepressant treatment than those in the CBT group.
Seven patients (8%) did not start the first treatment session
and were unaware of treatment allocation (Figure 1). Completers
of all time points did not significantly differ from non-completers
(i.e., missing at least one time point) on gender, education, and
years of complaints. No unintended effects were found in both
treatment groups.
Primary Outcome Measures
Information on observed outcomemeans and effect sizes for both
treatment groups for all time points, are presented in Table 2.
The intention-to-treat analyses at T3 were performed on 39
TABLE 1 | Baseline demographic and clinical characteristics.
Characteristics CBT (N = 42) EMDR (N = 42) Total sample (N = 84) P
Age, mean (SD), year 40.9 (12.1) 37.0 (10.7) 39.0 (11.5) 0.126a
Gender, No. 0.491b
Male 16 13 29
Female 26 29 55
Education, No. (%) 0.143b
Low (<10 years) 9 (21%) 13 (31%) 22 (26%)
Middle (10–14 years) 24 (57%) 15 (36%) 39 (46%)
High (>14 years) 9 (21%) 14 (33%) 23 (27%)
Marital status, No. (%) 0.078b
Unmarried 20 (48%) 28 (67%) 48 (57%)
Married 22 (52%) 14 (33%) 36 (43%)
Duration of PD, No. (%) 0.027b*
<2 years 25 (60%) 12 (29%) 37 (44%)
2–5 years 8 (19%) 12 (29%) 20 (24%)
5–10 years 2 (5%) 8 (20%) 10 (12%)
>10 years 7 (17%) 9 (22%) 16 (19%)
Missing 0 1 1 (1%)
DSM-IV-TR Axis I diagnosesa, mean (SD) 2.5 (1.1) 2.5 (1.1) 2.5 (1.1) 0.766a
AgoraphobiaI, No. (%) 33 (80%) 28 (68%) 61 (74%) 0.161b
Received previous treatment for PD, No. (%) 0.001b**
Yes 18 (43%) 33 (79%) 51 (61%)
No 24 (57%) 9 (21%) 33 (39%)
Received antidepressant treatment No. (%) 0.026b*
Yes 12 (29%) 22 (52%) 34 (40%)
No 30 (71%) 20 (48%) 50 (60%)
CBT, cognitive behavioral therapy; EMDR, eye movement desensitization and reprocessing; PD, Panic Disorder; SCID-I, Structured Clinical Interview for DSM-IV Axis I disorders; SD,
standard deviation.
IMeasured using SCID-I.
a Independent two-sampled t-test.
bPearson Chi-Square.
*p < 0.05.
**p < 0.01.
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TABLE 2 | Observed outcome means (standard deviation) for both treatment groups EMDR and CBT for baseline (T1), after treatment (T2), and 3 months follow up (T3).
CBT EMDR
Outcome T1 (N = 38) T2 (N = 28) T3 (N = 25) T1 (N = 39) T2 (N = 34) T3 (N = 29)
Mean (SD) Mean (SD) da Mean (SD) db Mean (SD) Mean (SD) da Mean (SD) db
SYMPTOMSa
ACQ 34.1 (9.6) 24.7 (8.8) −0.86 27.5 (10.7) −0.60 36.8 (12.1) 23.6 (10.5) −1.21 25.1 (10.2) −1.07
BSQ1 47.0 (11.8) 29.1 (9.4) −1.44 34.1 (12.1) −1.04 50.2 (13.0) 28.5 (10.4) −1.74 30.2 (11.5) −1.60
BSQ2 48.3 (11.2) 34.5 (9.9) −1.25 40.3 (10.9) −0.72 52.5 (10.7) 33.0 (12.4) −1.77 36.3 (14.0) −1.47
MI-ac 51.9 (18.8) 33.3 (9.7) −0.99 35.2 (11.2) −0.89 51.8 (19.1) 36.6 (16.9) −0.80 36.2 (15.8) −0.83
MI-al 62.2 (22.8) 41.3 (14.8) −0.85 43.3 (17.3) −0.77 68.1 (26.0) 42.0 (21.7) −1.06 41.4 (17.5) −1.09
QOLb
OQOL/GH 10.8 (3.6) 14.4 (2.4) 1.00 13.0 (3.8) 0.62 10.6 (3.5) 14.7 (3.8) 1.16 15.3 (2.7) 1.33
Physical health 11.9 (2.6) 14.4 (2.4) 0.91 14.0 (2.7) 0.75 11.2 (3) 14.7 (3.1) 1.26 14.5 (2.5) 1.18
Psychological health 11.0 (2.5) 13.3 (1.8) 0.91 12.9 (2.7) 0.78 11.0 (2.6) 14.3 (2.8) 1.32 14.5 (2.1) 1.39
Social relationships 13.4 (2.8) 15.0 (2.6) 0.55 14.6 (2.3) 0.42 14.1 (3.0) 15.6 (3.0) 0.55 15.0 (2.5) 0.32
Environment 14.0 (2.3) 15.7 (1.9) 0.70 15.5 (2.1) 0.62 13.8 (2.5) 16.4 (2.4) 1.05 15.9 (1.9) 0.88
ACQ, Agoraphobic Cognitive Questionnaire; BSQ1, Body Symptoms Questionnaire (amount of fear); BSQ2, Body Symptoms Questionnaire (how often sensations are experienced);
CBT, Cognitive Behavioral Therapy; EMDR, Eye Movement Desensitization and Reprocessing; MI-ac, Mobility Inventory (when accompanied); MI-al, Mobility Inventory (when alone);
QOL, Quality Of Life; OQOL/GH. Overall Quality Of Life and General Health; d, Mean difference divided by pooled (CBT+ EMDR) baseline standard deviation; da, d(T2-T1); db, d(T3-T1).
TABLE 3 | Non-inferiority effects EMDR vs. CBT at T3.
Unadjusted Adjustedf
Outcome B (EMDR-CBT) Lower 90%CI Upper 90%CI B (EMDR-CBT) Lower 90%CI Upper 90%CI
SYMPTOMSa
ACQc −2.68 −7.11 1.75* −3.05 −7.92 1.82*
BSQ1c −4.09 −9.26 1.08* −3.40 −9.08 2.28*
BSQ2c −4.50 −9.98 0.98* −6.02 −11.97 −0.06*
MI-acd 0.74 −5.09 6.58* 2.83 −3.61 9.28
MI-ald −0.28 −7.56 7.00* 2.44 −5.21 10.09
QOLb
OQOL/GHe 1.95 0.53* 3.37 1.25 −0.23* 2.74
Physical healthe 0.51 −0.58* 1.61 −0.07 −1.27 1.13
Psychological healthe 1.55 0.47* 2.62 1.41 0.29* 2.54
Social relationshipse 0.41 −0.64* 1.45 0.47 −0.66* 1.60
Environmente 0.47 −0.42* 1.36 0.02 −0.97* 1.01
ACQ, Agoraphobic Cognitive Questionnaire; B, unstandardized effect estimate; BSQ1, Body Symptoms Questionnaire (amount of fear); BSQ2, Body Symptoms Questionnaire (how
often sensations are experienced); CBT, Cognitive Behavioral Therapy; CI, Confidence Interval; EMDR, Eye Movement Desensitization and Reprocessing; MI-ac, Mobility Inventory (when
accompanied); MI-al, Mobility Inventory (when alone); QOL, Quality Of Life; OQOL/GH, Overall Quality Of Life and General Health.
aLower scores indicates better for patient.
bHigher scores indicates better for patient
cNoninferiority test: upper bound 90% CI < 5.
dNoninferiority test: upper bound 90% CI < 8.
eNoninferiority test: lower bound 90% CI > (−1).
fAdjusted for age, gender, education, marital status, duration of complaint, received previous treatment, number of axis I diagnoses and antidepressant.
*Indicates non-inferiority.
EMDR patients and 38 CBT patients. Scores on questionnaires
measuring severity of PD (ACQ, BSQ1, BSQ2, MI-ac, and MI-
al) showed non-inferiority of EMDR to CBT in the unadjusted
analysis (Table 3, Figure 2A). In the adjusted analysis, this was
also the case for ACQ, BSQ1, and BSQ2, whereasMI-ac andMI-al
were inconclusive.
Secondary Outcome Measures
For the facet ‘Overall QOL and general health’ and the
four QOL domains, EMDR appeared to be non-inferior to
CBT at T3 in the unadjusted analysis (Table 3, Figure 2B).
For the adjusted analyses, only “physical health” was
inconclusive.
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FIGURE 2 | Unadjusted effects and 90% CI of (A) the symptoms and (B) the quality of life facet and domains at T3. ACQ, Agoraphobic Cognitive Questionnaire;
BSQ1, Body Symptoms Questionnaire (amount of fear); BSQ2, Body Symptoms Questionnaire (how often sensations are experienced); CBT, Cognitive Behavioral
Therapy; CI, Confidence Interval; EMDR, Eye Movement Desensitization and Reprocessing; MI-ac, Mobility Inventory (when accompanied); MI-al, Mobility Inventory
(when alone); QOL, Quality Of Life; OQOL/GH, Overall Quality Of Life and General Health.
Sensitivity Analyses
Per-protocol analyses included the 62 patients that had T1
and T2 measurement (10 patients were removed in the CBT
group and five in the EMDR group). All conclusions were
similar to the intention-to-treat analyses, except for QOL domain
“Environment” in which the unadjusted analysis at T3 was now
inconclusive (lower bound−1.09).
DISCUSSION
This is the first RCT that tested whether EMDR is no worse
than CBT (i.e., the “gold standard” for the treatment of PD).
The results show that EMDR is no worse (i.e., non-inferior) than
CBT with regard to severity of a wide range of PD symptoms,
including anxiety related cognitions, fear of bodily sensations,
as well as quality of life. Concerning the behavioral aspects
of the condition, the tendency to avoid certain situations, the
results were inconclusive. Intriguingly, despite both treatments
were comparable in terms of effects, from face value the
procedures seem to be opposed. That is, the CBT procedure
for panic disorder entails specific exposures to patient’s physical
sensations (i.e., sensory experiences associated with anxiety, i.e.,
the conditioned stimuli), while disturbing memories of past
events (the unconditioned stimuli, e.g., the first panic attack),
that may have laid the groundwork for the panic disorder, are
left untreated. In contrast, in EMDR therapy only memories of
the latter type of events are targeted and processed, whereas
the protocol only indirectly deals with the stimuli that normally
would evoke a panic attack.
A strength of the current study is the use of manualized
treatment protocols, including a relatively long therapeutic track
consisting of 13 sessions making generalizability to clinical
practice more feasible.
A limitation of the current study is the use of audio tones
as the modality by which the memory taxation was performed.
Laboratory studies provide evidence that audio tones are less
optimal or appeared even less effective when compared to
eye movements in diminishing the emotionality of memories
underlying PTSD and other mental health problems (Van
den Hout et al., 2012; De Jongh et al., 2013). This implies
that when eye movements would have been applied in the
present study the results might have been more profound.
Furthermore, the determined sample size was not reached.
Therefore, the study was underpowered given the expected effect
size. Nonetheless, results showed larger effects sizes than a-
priori expected, particularly for EMDR therapy. Concerning
our randomization, it appeared that the two treatment groups
differed on three aspects. Patients receiving CBT had a shorter
PD duration, less previous treatment, and less antidepressant
treatment compared to patients receiving EMDR. With regard
the dropout rate, this was higher than expected, especially in
the CBT group. This might partly be explained by the fact that
Dutch law states that patients’ decision to participate in scientific
studies is voluntary, which means that patients may withdraw
from the study at any timewithout specifying a reason. Therefore,
we cannot provide a definite explanation for all patients. Another
reason could be that patients who used benzodiazepines or other
sedative agents were asked to stop medication so they could
enter the study when clean. When patients asked for support,
they were offered a clinical detox. Several patients refused to
stop medication and therefore, received treatment as usual, and
stopped participating in the study. Finally, no fidelity measure
was used for CBT interoceptive exposure. To our knowledge,
no such measure exists and developing and validating such a
measure was beyond the scope of the current research. For
EMDR fidelity measures do exist, but reporting this on its own
seemed inappropriate.
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Future long-term studies may provide more insight into
the stability of the effects. This study has focused directly on
comparing CBT with EMDR in the treatment of PD. Concerning
the small sample size and the inconclusive results with regard to
the MI, future studies may focus on combining both therapies,
and especially on in vivo exposure with EMDR.
In conclusion, the present results provided evidence
suggesting that EMDR therapy is as effective as CBT for patients
with PD and may, therefore, be considered as a useful alternative
to a conventional CBT treatment of PD patients.
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